This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
Three strategies were considered: nonsurgical management, total wrist arthroplasty, and total wrist arthrodesis.
Location/setting
USA/hospital and secondary care.
Methods

Analytical approach:
The analysis was based on a decision analytic model, with a time horizon of 30 years. The authors stated that a societal perspective was adopted.
Effectiveness data:
A systematic review of the literature was undertaken to identify the key clinical inputs, which were the probabilities of complications (minor, intermediate, or major). Some assumptions were required where no published data were available.
Monetary benefit and utility valuations:
The utility values were from responses to a time trade-off survey in a sample of 49 consecutive patients with rheumatoid arthritis and a national random sample of 109 health care professionals. The patients were recruited from both a hand surgery clinic and a rheumatology clinic for a prospective study. The professionals were hand surgeons or rheumatologists. The survey response rate was 39% for physicians (109 of 300) and 98% for patients (49 out of 50).
Measure of benefit:
Quality-adjusted life-years (QALYs) were the benefit measure.
Cost data:
The economic analysis included the costs of surgeons, anaesthesia, out-patient surgery centre, and nonsurgical management (consultations, medications, splinting, and exercises). Lost productivity due to both disease and treatment was excluded as most patients were likely to be unemployed or unable to work both before and after surgery. The analysis also included the costs of complications. Most of the costs were based on national standards from the Medicare
